Plain-English translation of NCT06348498 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Read our Heart Failure research guide โPhase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This is an early-stage clinical trial testing Jia Shen Tablets, an oral herbal medicine made from traditional Chinese medicine ingredients. The trial will look at how the medication works in your body and whether it helps treat heart failure in people who also have coronary heart disease. Researchers want to understand both how safe and how effective this treatment is.
Heart failure is a serious condition where the heart doesn't pump blood effectively, and current treatments don't work well enough for everyone. This medication aims to address a specific pattern of heart failure that traditional Chinese medicine calls 'yang deficiency with blood stasis,' and researchers want to see if it could offer additional help alongside standard treatments.
You would take 4 tablets of the medication by mouth twice daily. The study is single-center, meaning all visits happen at one location. Researchers will monitor how your body processes the medication and whether it helps your heart function improve, likely through blood tests and heart imaging over a study period. You would need to continue your regular heart failure medications while participating.
AI-generated summary from trial data ยท Jun 2, 2026 ยท Not medical advice
China
Phase
Safety & dosing
Sponsor
Tasly Pharmaceutical Group Co., Ltd
Enrollment target
~18 participants
Started
April 2024
Primary completion
June 2026
Age range
18 Years โ 75 Years
Last updated on clinicaltrials.gov in June 2024.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Rui Liu
Tasly Pharmaceutical Group Co., Ltd